Lassa virus uses unexpected two-step mechanism to enter cells

June 27, 2014
Lassa virus uses unexpected two-step mechanism to enter cells
Lassa fever is endemic to West Africa. Countries in green report substantial outbreaks and countries in blue report fewer cases. Credit: CDC

(Medical Xpress)—The Lassa virus is a dangerous microbe. Endemic to West Africa and spread by a rodent, it causes infections in humans that can lead to a severe and deadly hemorrhagic fever. There are an estimated 500,000 infections and 100,000 fatalities per year in West Africa from this fever.

More than 30 years ago, researchers discovered that while the virus can infect a broad range of cells from different species, it doesn't infect chicken cells. What makes this puzzling is that bird cells have the same cell-surface receptor as other species, a protein that the virus uses to hook onto cells and enter them. So how do birds avoid infection?

Now, an international research team comprising investigators from Harvard Medical School and the Netherlands Cancer Institute has solved this mystery, leading to a better understanding of how Lassa virus infects mammals. Using genetic screens, they determined that a second protein called LAMP1 is essential for the virus to properly infect cells. Their results were published in the journal Science on June 27.

The identification of LAMP1 as a Lassa virus receptor now presents a new target for potential intervention, said Sean Whelan, HMS professor of microbiology and immunobiology. A co-corresponding author of the paper, he noted that the research is central to work done as part of a Center of Excellence for Translational Research in virology at HMS. The center is focused on the development of small-molecule inhibitors of enveloped virus entry.

"Importantly, the work also suggests why it has been historically difficult to identify receptors for many viruses using traditional biochemical assays," he said. "By using a hidden on an interior membrane, the virus can sequester its potentially vulnerable receptor binding site from neutralizing antibody."

Lassa virus uses unexpected two-step mechanism to enter cells
Sample of liver tissue infected with Lassa virus. Credit: CDC

The genetic discoveries were validated in mice by a team led by John Dye at the U.S. Army Medical Research Institute of Infectious Diseases and at the University of Kiel in Germany. Mice engineered to lack the LAMP1 protein were not susceptible to the Lassa virus.

It turns out that when Lassa virus grabs onto a receptor on the cell surface, it is first transported to a structure inside the cell called a lysosome. Lysosomes are the "garbage cans" of cells, breaking down a variety of molecules in the cell's hostile interior. To infect the cell, Lassa virus needs to escape the lysosome. It does so by hooking onto LAMP1, which appears to be an unknown type of interior cell receptor for the virus.

"From a virology point of view, this second part of our discovery is the most interesting," said first author Lucas Jae of the Netherlands Cancer Institute. "The identity of the receptor on the cell surface has been known for 15 years. Nobody expected there to be a second receptor inside of the cell."

The scientists also discovered that the critical difference between the avian version of the LAMP1 protein and its human counterpart lies within a single additional sugar structure, present in humans but absent in birds.

Three years ago the team from HMS, USAMRIID and the Netherlands Cancer Institute, together with Kartik Chandran at Albert Einstein College of Medicine, found a similar two-step mechanism for the entry of Ebola virus into cells.

"We now suspect that more viruses may require multiple receptors to reach the cytoplasm," said Thijn Brummelkamp, a co-corresponding author of the current Science paper. "If this turns out to be true, the process by which viruses infect is more complicated than currently stated in the textbooks."

Explore further: Learning from Lassa virus: Researchers discover gene mutations that can result in a congenital disorder

More information: Lassa virus entry requires a trigger-induced receptor switch, by L.T. Jae; M. Raaben et al. www.sciencemag.org/lookup/doi/ … 1126/science.1252480

Related Stories

Learning from Lassa virus: Researchers discover gene mutations that can result in a congenital disorder

March 22, 2013
(Medical Xpress)—Researchers have known that two seemingly distant human maladies—a devastating set of hereditary disorders called Walker-Warburg syndrome and infection with the virus that causes hemorrhagic Lassa fever—both ...

Hemorrhagic fevers can be caused by body's antiviral interferon response

June 4, 2014
Hemorrhagic fevers caused by Lassa, dengue and other viruses affect more than one million people annually and are often fatal, yet scientists have never understood why only some virus-infected people come down with the disease ...

Virus kills triple negative breast cancer cells, tumor cells in mice

June 24, 2014
A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer ...

Cell receptor could allow measles virus to target tumors

August 25, 2011
Canadian researchers have discovered that a tumor cell marker is a receptor for measles virus, suggesting the possible use of measles virus to help fight cancer. Their findings appear in the Open Access journal PLoS Pathogens ...

Researchers unlock how Ebola virus smashes into human cells

June 2, 2014
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have discovered how the deadly Ebola virus punches its way into the cytoplasm of cells. The finding identifies an important target for blocking ...

Recommended for you

Study finds harmful protein on acid triggers a life-threatening disease

July 27, 2017
Using an array of modern biochemical and structural biology techniques, researchers from Boston University School of Medicine (BUSM) have begun to unravel the mystery of how acidity influences a small protein called serum ...

CRISPR sheds light on rare pediatric bone marrow failure syndrome

July 27, 2017
Using the gene editing technology CRISPR, scientists have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.

Post-stroke patients reach terra firma with new exosuit technology

July 26, 2017
Upright walking on two legs is a defining trait in humans, enabling them to move very efficiently throughout their environment. This can all change in the blink of an eye when a stroke occurs. In about 80% of patients post-stroke, ...

Molecular hitchhiker on human protein signals tumors to self-destruct

July 24, 2017
Powerful molecules can hitch rides on a plentiful human protein and signal tumors to self-destruct, a team of Vanderbilt University engineers found.

Researchers develop new method to generate human antibodies

July 24, 2017
An international team of scientists has developed a method to rapidly produce specific human antibodies in the laboratory. The technique, which will be described in a paper to be published July 24 in The Journal of Experimental ...

New vaccine production could improve flu shot accuracy

July 24, 2017
A new way of producing the seasonal flu vaccine could speed up the process and provide better protection against infection.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

kelman66
1 / 5 (1) Jun 27, 2014
But what has Science done for us lately? oh wait.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.